Below is a list of forthcoming submissions that have recently been added to the SMC's programme:

• Budesonide (Budenofalk) - new indication
• Fingolimod hydrochloride (Gilenya) - new indication
• Idelalisib (Zydelig) - new medicine
• Linagliptin with metformin hydrochloride (Trajentamet) - new combination product
• Liraglutide (Victoza) - new indication
• Ofatumumab (Gazyva) - new medicine
• Vedolizumab (Entyvio) - new medicine

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions